12:00 AM
Aug 21, 2000
 |  BC Week In Review  |  Company News  |  Other News

Biogen, Berlex autoimmune/inflammation news

BGEN said the U.S. District Court for the District of Massachusetts issued a summary judgement that the company's Avonex beta interferon for...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >